#news #biotech GSK, after pushing past midphase fail, ends development of otilimab in COVID-19

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: GSK, after pushing past midphase fail, ends development of otilimab in COVID-19 .GSK, after pushing past midphase fail, ends development of otilimab in COVID-19
ntaylor
Wed, 10/27/2021 – 08:58

from FierceBiotech: Biotech https://ift.tt/3nAgorW